ANALYSIS OF EFFICACY AND SAFETY OF LONCASTUXIMAB TESIRINE (ADCT‐402) BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) - Radford, J.; Kahl, B.; Hamadani, M.; Carlo‐Stella, C.; O'Connor, O.A.; Ardeshna, K.M.; Feingold, J.; He, S.; Reid, E.; Solh, M.; Chung, K.; Heffner, L.; et al.